The link you followed will bring you to this page:

https://www.eventiavversinews.it/il-giapponese-kowa-in-collaborazione-con-la-kitasato-university-presso-la-tokyo-medical-university-livermectina-e-efficace-contro-omicron-in-uno-studio-di-fase-iii/